Senior insider sale
EVP, Chief Technical Ops. Off. at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$2.89M
6.28K shares
What this filing means
ATKINSON EDWARD MORROW III plans to sell 6.28K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $2.89M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/17/2026ACC: 0001959173-26-001034
Officer· EVP, Chief Technical Ops. Off.
Since Feb 2026
6.28K
Shares to sell
$2.89M
Approx. market value
2.03K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/13/2026
2.03KTotal acquired2.03K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/13/2026 | Restricted Stock Vesting Compensation | 2.03K | — |
| Total | 2.03K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
1.75K
Market value
$806.2K
2/11/2026
—Completed
Units to sell
2.50K
Market value
$1.09M
11/17/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.03K
Market value
$994.1K
2/17/2026
Total
Units
6.28K
Value
$2.89M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/11/2026 | 1.75K | $806.2K | — | Completed |
11/17/2025 | 2.50K | $1.09M | — | Completed |
| Planned — Approximate Date | ||||
2/17/2026 | 2.03K | $994.1K | NASDAQ | Planned |
| Total | 6.28K | $2.89M | ||